AlloVir, Inc. (ALVR)
Mar 18, 2025 - ALVR was delisted (reason merged into KLRS)
9.81
+0.39 (4.14%)
Inactive · Last trade price on Mar 18, 2025

AlloVir Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for AlloVir.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for AlloVir.

Recommendation Trends

Rating Aug '23Sep '23Oct '23Nov '23Dec '23Jan '24
Strong Buy 111100
Buy 333300
Hold 000030
Sell 000020
Strong Sell 000000
Total 444450

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Morgan Stanley
Morgan Stanley
Sell
Downgrades
$23$12
Sell Downgrades $23$12 +17.23% Jan 5, 2024
B of A Securities
B of A Securities
Sell
Downgrades
$391$23
Sell Downgrades $391$23 +134.45% Dec 26, 2023
Morgan Stanley
Morgan Stanley
Hold
Downgrades
$460$23
Hold Downgrades $460$23 +134.45% Dec 22, 2023
Leerink Partners
Leerink Partners
Hold
Downgrades
$23
Hold Downgrades $23 +134.45% Dec 22, 2023
Piper Sandler
Piper Sandler
Hold
Downgrades
$621$35
Hold Downgrades $621$35 +251.68% Dec 22, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.30
EPS Next Year
-0.45
from -0.30
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
--------
Revenue Growth
--------
EPS
-59.67-63.00-50.62-42.09--0.30-0.45-
EPS Growth
--------
Forward PE
--------
No. Analysts -----643
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202520262027
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20252026
High -0.05 -0.46
Avg -0.30 -0.45
Low -0.49 -0.43

EPS Growth

EPS Growth 20252026
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.